Standard Chartered Plans to Reduce Corporate Functions Roles by Over 15 as Part of Efficiency Drive CashRich Automotive Underdog May Present Value Opportunity Amid Tesla Premium Federal Reserve Loses Impetus for Rate Cuts as Jobs Data Signals Persistent Inflation Credit Suisse Analyst Projects Repo Rate to Hit Decade Low Signals Potential Market Rally from December Vestas Wind Systems Shares Decline After Margins Guidance Disappoints Andy Burnhams Political Rise Implications for UK Regional Investment and Devolution Policy CEVA Q1 2026 Earnings EPS Surges Past Estimates Stock Declines Despite Beat General Motors Q1 2026 Earnings Strong EPS Beat Drives Stock Higher SNFCA Q4 2025 Earnings Earnings per share of 053 reported stock edges lower RCUS Q1 2026 Earnings EPS Misses Estimates Despite Stock Uptick COTY Q1 2026 Earnings EPS Misses Estimates by Wide Margin Revenue Data Unavailable AvePoint AVPT Edges Higher Amid Steady Trading Key Support and Resistance Levels in Focus Coffee Holding Co JVA Edges Higher Holds Above Key Support Level TMD Energy TMDE Edges Lower as Stock Approaches Key Support Near 073 Alpha Tau Medical DRTS Slides 84 as Shares Test Support Levels CocaCola Europacific Partners CCEP Holds Steady Near 94 Key Levels and Trading Dynamics Dyadic International DYAI Slides Lower Testing Key Support Near 072 Hoyne Bancorp Inc HYNE Slips 044 as Shares Trade in Narrow Range Support and Resistance Hold Firm Lamar Advertising LAMR Edges Higher as Billboard REIT Tests Key Support Zone T3 Defense Inc DFNS Surges Over 18 as Defense Sector Momentum Builds Oculis Holding AG Warrants OCSAW Hold Steady Near Support as Market Awaits Catalysts US Stock Futures Decline Amid Reports of Putins Updated Nuclear Doctrine ASR Q1 2026 Earnings EPS Falls Short of Estimates Amid Operational Headwinds NTAP Q1 2026 Earnings Slight EPS Beat Drives Positive Stock Reaction GSK Q1 2026 Earnings EPS Surprise Beats Estimates Stock Slips Slightly Gladstone Capital Corporation GLAD Q1 2026 Earnings EPS Miss Disappoints as Stock Slips IQST Q4 2025 Earnings Deep EPS Miss as Losses Widen Revenue Data Unavailable Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 Vertical Aerospace Q4 2025 Earnings EPS Miss Reflects Ongoing RD Investment PreRevenue Status Maintained NTIP Q1 2026 Earnings Net Loss of 002 Reported Stock Dips 067